134 related articles for article (PubMed ID: 10357037)
1. Altered [3H]imipramine and 5-HT2 but not [3H]paroxetine binding sites in platelets from depressed patients.
Rosel P; Arranz B; Vallejo J; Alvarez P; Menchon JM; Palencia T; Navarro MA
J Affect Disord; 1999; 52(1-3):225-33. PubMed ID: 10357037
[TBL] [Abstract][Full Text] [Related]
2. Platelet [3H]imipramine and [3H]paroxetine binding in depressed patients.
Rosel P; Menchón JM; Vallejo J; Arranz B; Navarro MA; Lirón F; Alvarez P
J Affect Disord; 1997 Jun; 44(1):79-85. PubMed ID: 9186805
[TBL] [Abstract][Full Text] [Related]
3. Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine.
Lawrence KM; Falkowski J; Jacobson RR; Horton RW
Psychopharmacology (Berl); 1993; 110(1-2):235-9. PubMed ID: 7870891
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of platelet 3H-paroxetine and 3H-imipramine binding in panic disorder patients and healthy controls.
Faludi G; Tekes K; Tóthfalusi L
J Psychiatry Neurosci; 1994 Mar; 19(2):109-13. PubMed ID: 8204562
[TBL] [Abstract][Full Text] [Related]
5. Variations in [3H]imipramine and 5-HT2A but not [3H]paroxetine binding sites in suicide brains.
Rosel P; Arranz B; Vallejo J; Oros M; Crespo JM; Menchon JM; Navarro MA
Psychiatry Res; 1998 Jun; 82(3):161-70. PubMed ID: 9754440
[TBL] [Abstract][Full Text] [Related]
6. High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes.
Mellerup ET; Plenge P; Engelstoft M
Eur J Pharmacol; 1983 Dec; 96(3-4):303-9. PubMed ID: 6233162
[TBL] [Abstract][Full Text] [Related]
7. Circannual variations in the binding of [3H]lysergic acid diethylamide to serotonin2A receptors and of [3H]paroxetine to serotonin uptake sites in platelets from healthy volunteers.
Spigset O; Allard P; Mjörndal T
Biol Psychiatry; 1998 May; 43(10):774-80. PubMed ID: 9606533
[TBL] [Abstract][Full Text] [Related]
8. Association of [3H]-imipramine and [3H]-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression.
Langer SZ; Galzin AM; Poirier MF; Loo H; Sechter D; Zarifian E
J Recept Res; 1987; 7(1-4):499-521. PubMed ID: 3040983
[TBL] [Abstract][Full Text] [Related]
9. Enhanced displacement of [3H]imipramine, but not [3H]paroxetine binding by plasma from depressed patients.
Lawrence KM; Lowther S; Falkowski J; Jacobson RR; Horton RW
J Affect Disord; 1997 Nov; 46(2):127-34. PubMed ID: 9479616
[TBL] [Abstract][Full Text] [Related]
10. Loss of the circadian variation of platelet [3H]imipramine binding in delusional compared with non-delusional endogenously depressed patients.
Vallejo J; Rosel P; Arranz B; Urretavizcaya M; Menchón JM; Contreras F; Navarro MA
J Affect Disord; 2002 Oct; 72(1):95-101. PubMed ID: 12204323
[TBL] [Abstract][Full Text] [Related]
11. Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients.
Arora RC; Meltzer HY
Life Sci; 1989; 44(11):725-34. PubMed ID: 2927243
[TBL] [Abstract][Full Text] [Related]
12. Studies on the serotonin transporter in platelets.
Langer SZ; Galzin AM
Experientia; 1988 Feb; 44(2):127-30. PubMed ID: 2964377
[TBL] [Abstract][Full Text] [Related]
13. [3H-Imipramine binding to human platelets. A peripheral index in depressive syndromes (author's transl)].
Zarifian E; Sechter D; Bouchami F; Cuche H; Olie JP; Susini JR; Loo H; Briley M; Raisman R; Langer SZ
Nouv Presse Med; 1982 Apr; 11(18):1385-7. PubMed ID: 7079155
[TBL] [Abstract][Full Text] [Related]
14. Platelet 3H-paroxetine binding in control subjects and depressed patients: relationship to serotonin uptake and age.
Nankai M; Yamada S; Yoshimoto S; Watanabe A; Mori H; Asai K; Toru M
Psychiatry Res; 1994 Feb; 51(2):147-55. PubMed ID: 8022949
[TBL] [Abstract][Full Text] [Related]
15. Further studies on platelet serotonin transporter binding in depression.
Nemeroff CB; Knight DL; Franks J; Craighead WE; Krishnan KR
Am J Psychiatry; 1994 Nov; 151(11):1623-5. PubMed ID: 7943450
[TBL] [Abstract][Full Text] [Related]
16. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine.
Alvarez JC; Gluck N; Arnulf I; Quintin P; Leboyer M; Pecquery R; Launay JM; Perez-Diaz F; Spreux-Varoquaux O
Clin Pharmacol Ther; 1999 Dec; 66(6):617-24. PubMed ID: 10613618
[TBL] [Abstract][Full Text] [Related]
17. Imipramine binding site. Temperature dependence of the binding of 3H-labeled imipramine and 3H-labeled paroxetine to human platelet membrane.
Plenge P; Mellerup ET
Biochim Biophys Acta; 1984 Feb; 770(1):22-8. PubMed ID: 6230106
[TBL] [Abstract][Full Text] [Related]
18. Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain.
Rosel P; Menchon JM; Oros M; Vallejo J; Cortadellas T; Arranz B; Alvarez P; Navarro MA
J Neural Transm (Vienna); 1997; 104(1):89-96. PubMed ID: 9085196
[TBL] [Abstract][Full Text] [Related]
19. Paroxetine shifts imipramine metabolism.
Albers LJ; Reist C; Helmeste D; Vu R; Tang SW
Psychiatry Res; 1996 Jan; 59(3):189-96. PubMed ID: 8930024
[TBL] [Abstract][Full Text] [Related]
20. A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients.
van den Broek WW; Birkenhäger TK; Mulder PG; Bruijn JA; Moleman P
Psychopharmacology (Berl); 2004 Oct; 175(4):481-6. PubMed ID: 15243735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
